Showing results (1-10 of 241) with videos related to
Sort By:
Pageof 25
Immunology|August 14, 1999
Do self-perpetuating B lymphocytes drive human autoimmune disease?J C Edwards, G Cambridge, V M AbrahamsArthritis and Rheumatism|March 23, 2000
Induction of tumor necrosis factor alpha production by adhered human monocytes: a key role for Fcgamma receptor type IIIa in rheumatoid arthritisV M Abrahams, G Cambridge, P M Lydyard, et al.Rheumatology (Oxford, England)|March 21, 2001
Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytesJ C Edwards, G CambridgeClinical and Experimental Immunology|June 1, 1997
Restricted expression of Fc gammaRIII (CD16) in synovium and dermis: implications for tissue targeting in rheumatoid arthritis (RA)J C Edwards, S Blades, G CambridgeClinical and Experimental Immunology|June 1, 1997
Expression of molecules involved in B lymphocyte survival and differentiation by synovial fibroblastsJ C Edwards, R D Leigh, G CambridgeImmunology|August 26, 1998
Differential distribution of Fc gamma RIIIa in normal human tissues and co-localization with DAF and fibrillin-1: implications for immunological microenvironmentsA Bhatia, S Blades, G Cambridge, et al.British Journal of Rheumatology|April 1, 1993
Intercellular adhesion molecules in normal synoviumK Fairburn, M Kunaver, L S Wilkinson, et al.Rheumatology (Oxford, England)|September 29, 2005
B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patientsM J Leandro, G Cambridge, J C Edwards, et al.Annals of the Rheumatic Diseases|November 5, 2005
Repeated B cell depletion in treatment of refractory systemic lupus erythematosusK P Ng, M J Leandro, J C Edwards, et al.Arthritis and Rheumatism|November 1, 2006
B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profilesG Cambridge, M J Leandro, M Teodorescu, et al.Pageof 25